Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effects of Flibanserin on the Pre- and Post-menopausal Female Brain

Not Applicable

Terminated

Conditions: Hypoactive Sexual Desire Disorder

Interventions: Drug: Flibanserin
Drug: Placebo

First Posted Date: 2016-05-12

Last Posted Date: 2024-05-16

Lead Sponsor: University of Chicago

Target Recruit Count: 57

Registration Number: NCT02770768

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis

Phase 4

Completed

Conditions: Heart Failure

Interventions: Drug: Entresto

First Posted Date: 2016-04-28

Last Posted Date: 2021-01-29

Lead Sponsor: University of Chicago

Target Recruit Count: 40

Registration Number: NCT02754518

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Partner Services Pre-exposure Prophylaxis (PS-PrEP)

Not Applicable

Active, not recruiting

Conditions: HIV Transmission, Transtheoretical Model of Change

Interventions: Behavioral: PS-PrEP Intervention Group
Behavioral: PrEPLine Control Group

First Posted Date: 2016-04-25

Last Posted Date: 2024-12-27

Lead Sponsor: University of Chicago

Target Recruit Count: 164

Registration Number: NCT02749955

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain

Not Applicable

Withdrawn

Conditions: Autosomal Dominant Polycystic Kidney Disease

Interventions: Device: Vessix

First Posted Date: 2016-04-21

Last Posted Date: 2019-04-03

Lead Sponsor: University of Chicago

Registration Number: NCT02746419

Frameless Stereotactic Radiosurgery for Intact Brain Metastases

Phase 2

Suspended

Conditions: Brain Metastases

Interventions: Procedure: Stereotactic Radiosurgery

First Posted Date: 2016-04-21

Last Posted Date: 2024-12-20

Lead Sponsor: University of Chicago

Target Recruit Count: 166

Registration Number: NCT02747303

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma

Phase 2

Active, not recruiting

Conditions: Melanoma

Interventions: Drug: Pembrolizumab
Drug: Ipilimumab

First Posted Date: 2016-04-19

Last Posted Date: 2024-05-14

Lead Sponsor: University of Chicago

Target Recruit Count: 70

Registration Number: NCT02743819

Locations: 🇺🇸
Oncology Specialists S.C., Park Ridge, Illinois, United States
🇺🇸
University of South Alabama, Mobile, Alabama, United States
🇺🇸
Mount Sinai Medical Center of Florida, Miami Beach, Florida, United States

and more 7 locations

Vitamin D and Disease Activity in Ulcerative Colitis

Completed

Conditions: Ulcerative Colitis

First Posted Date: 2016-03-24

Last Posted Date: 2023-02-23

Lead Sponsor: University of Chicago

Target Recruit Count: 248

Registration Number: NCT02717897

A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

Phase 1

Terminated

Conditions: Pleural Mesothelioma

Interventions: Drug: Pembrolizumab
Drug: Cisplatin and Pemetrexed

First Posted Date: 2016-03-14

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 7

Registration Number: NCT02707666

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

Phase 2

Terminated

Conditions: FGFR1 Gene Amplification
FGFR2 Gene Amplification
FGFR2 Gene Mutation
Head and Neck Squamous Cell Carcinoma
FGFR Gene Amplification
Recurrent Nasopharynx Carcinoma
FGFR3 Gene Mutation
Human Papillomavirus Infection
Recurrent Head and Neck Carcinoma
Recurrent Oropharyngeal Squamous Cell Carcinoma

Interventions: Drug: BGJ398

First Posted Date: 2016-03-11

Last Posted Date: 2019-04-16

Lead Sponsor: University of Chicago

Target Recruit Count: 1

Registration Number: NCT02706691

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

His Bundle Pacing Versus Coronary Sinus Pacing for Cardiac Resynchronization Therapy

Not Applicable

Completed

Conditions: Congestive Heart Failure

Interventions: Device: CRT Pacemaker

First Posted Date: 2016-03-07

Last Posted Date: 2021-09-05

Lead Sponsor: University of Chicago

Target Recruit Count: 41

Registration Number: NCT02700425

Locations: 🇺🇸
Edward Hospital, Naperville, Illinois, United States
🇺🇸
Baptist Health Louisville, Louisville, Kentucky, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy